Bayesian Capital Management’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,750
Closed -$493K 680
2025
Q2
$493K Buy
+11,750
New +$425K 0.08% 282
2025
Q1
Sell
-52,100
Closed -$1.8M 786
2024
Q4
$1.8M Buy
+52,100
New +$1.52M 0.22% 140
2024
Q3
Sell
-18,740
Closed -$493K 873
2024
Q2
$493K Buy
18,740
+6,400
+52% +$153K 0.06% 374
2024
Q1
$269K Buy
+12,340
New +$262K 0.03% 585
2023
Q4
Sell
-64,828
Closed -$979K 896
2023
Q3
$979K Buy
64,828
+8,200
+14% +$122K 0.11% 229
2023
Q2
$752K Buy
56,628
+29,300
+107% +$397K 0.08% 323
2023
Q1
$403K Buy
+27,328
New +$388K 0.05% 446

Other funds holding KD

Bayesian Capital Management's KD Position: Q3 2025 in Review

Bayesian Capital Management sold out of Kyndryl (KD) in Q3 2025, closing a stake of 11,750 shares — an estimated $493K sold.

Bayesian Capital Management first reported a position in KD in Q1 2023 and held it in 7 quarters. The position peaked at $1.8M in Q4 2024. 689 funds tracked by Wall St. Rank hold KD as of Q3 2025.

  • Bayesian Capital Management reported no remaining Kyndryl position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 11,750 Kyndryl shares in Q3 2025, an estimated $493K.
  • Bayesian Capital Management first reported a position in Kyndryl in Q1 2023 and held it in 7 quarters.
  • Bayesian Capital Management's Kyndryl position peaked at $1.8M in Q4 2024.
  • 689 funds tracked by Wall St. Rank held Kyndryl as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.